Clinical Trial Update: Comparing Treatment Efficacy With High and Medium Dose of Fluticasone in Combination With Salmeterol in COPD Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing high-dose versus medium-dose fluticasone in combination with salmeterol for chronic obstructive pulmonary disease to evaluate treatment …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Fluticasone propionate (Fluticasone propionate)
• Salmeterol (salmeterol)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Percentage of Annual Acute Exacerbation, Quality of Life | Phase 4 | Status: UNKNOWN